Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis.
SGLT2抑制劑對NLRP3發炎小體的影響和機制,重點討論動脈粥樣硬化。
Front Endocrinol (Lausanne) 2023-01-26
Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19.
評估血漿生物標記物以預測住院COVID-19患者的重大不良腎臟事件。
Am J Kidney Dis 2024-03-12
Role of the CD40-CD40 Ligand Pathway in Cardiovascular Events, Neurological Alterations, and Other Clinical Complications of Chronic Hemodialysis Patients: Protective Role of Adsorptive Membranes.
慢性血液透析患者心血管事件、神經變化及其他臨床併發症中 CD40-CD40 Ligand 途徑的角色:吸附性膜的保護作用。
Blood Purif 2023-10-14
Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI.
腎小管和內皮細胞類型1 IL-1 受體訊號在毒素誘導性 AKI 中的分歧作用。
J Am Soc Nephrol 2024-02-10
Endothelial Biomarkers in Critically Ill COVID-19 Patients: Potential Predictors of the Need for Dialysis.
危重COVID-19患者中的內皮生物標記:預測是否需要透析的潛在指標。
Kidney Blood Press Res 2024-02-07
Minireview: Understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes.
小型綜述:了解並針對第一型糖尿病中的炎症、血流動力學和損傷標誌以保護心腎功能。
Metabolism 2024-03-04
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes.
RHAMM 升高作為預測 2 型糖尿病患者糖尿病腎病的生物標誌物。
Clin Kidney J 2024-07-26
RAGE/DIAPH1 and atherosclerosis through an evolving lens: Viewing the cell from the "Inside - Out".
RAGE/DIAPH1 與動脈粥樣硬化的演變視角:從「內部 - 外部」看細胞。
Atherosclerosis 2024-08-12